ACADIA Pharmaceuticals Inc. (ACAD) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | 33.98M | -48.73M | 74.29M | 63.96M | 20.32M | 40.38M | 63.25M | 25.01M | 29.08M | 85.39M | -58.95M | 8.2M |
| Operating CF Margin % | 12.68% | -17.16% | 26.66% | 24.17% | 8.32% | 15.55% | 25.26% | 10.34% | 14.13% | 36.96% | -27.85% | 4.96% |
| Operating CF Growth % | 67.2% | -220.68% | 17.46% | 155.69% | -30.11% | -52.71% | 207.28% | 205% | 262.15% | 457.97% | -8009.35% | 162.48% |
| Net Income | 3.64M | 273.57M | 71.78M | 26.67M | 18.99M | 143.74M | 32.77M | 33.39M | 16.55M | 45.8M | -65.18M | 1.11M |
| Depreciation & Amortization | 2.99M | 2.92M | 2.95M | -1.16M | 2.95M | 5.21M | 2.57M | 2.57M | 5.53M | 1.64M | 1.72M | 1.77M |
| Stock-Based Compensation | 0 | 0 | 13.18M | 14.34M | 11.38M | 10.45M | 26.16M | 15.69M | 14.75M | 18.02M | 18.54M | 15.15M |
| Deferred Taxes | -94K | -249.88M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -50.07M | 0 |
| Other Non-Cash Items | 14.24M | 12.56M | -1.1M | 2.56M | -2.12M | -149.33M | -2.75M | -1.95M | -1.79M | -1.78M | 46.59M | -247K |
| Working Capital Changes | 13.2M | -87.91M | -12.52M | 21.55M | -10.88M | 30.31M | 4.49M | -24.68M | -5.97M | 21.71M | -10.56M | -9.59M |
| Change in Receivables | -153K | -8.8M | -19.75M | -5.97M | -9.02M | 5.67M | 30K | -10.31M | 2.27M | -7.82M | -10.95M | -13.91M |
| Change in Inventory | 78K | -4.89M | 1.25M | -4.1M | -10.45M | -4.42M | -1.33M | -27.15M | -16.65M | -15.07M | -11.22M | -3M |
| Change in Payables | 1.34M | -10.84M | 1.65M | 2M | 1.9M | -2.89M | -801K | 550K | 1.79M | 5.23M | -6.5M | 1.39M |
| Cash from Investing | 66.28M | -55.87M | -79.35M | -43.29M | -124.05M | 122.15M | -82.46M | -56.19M | -14.04M | -347K | 34.11M | -194.28M |
| Capital Expenditures | -5.21M | -4M | -388K | 98.54M | -98.84M | -453K | -70K | 0 | 0 | 0 | -50K | -40M |
| CapEx % of Revenue | 1.94% | 1.41% | 0.14% | 37.25% | 40.45% | 0.17% | 0.03% | - | - | - | 0.02% | 24.21% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 50K | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | -98.84M | 0 | 146.51M | 0 | 0 | 0 | 0 | -50K | 0 |
| Cash from Financing | 4.23M | 22.67M | 9.42M | 15.96M | 1.84M | 1.97M | 268K | 3.56M | 1.04M | 5.43M | 12.75M | 5.48M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 4.23M | 22.67M | 9.42M | 15.96M | 1.84M | 1.97M | 268K | 3.56M | 1.04M | 5.43M | 12.75M | 5.48M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 104.52M | -80.3M | 4.36M | 36.64M | -101.89M | 164.44M | -18.98M | -27.61M | 16.09M | 90.46M | -12.1M | -182.95M |
| Free Cash Flow | 28.77M | -52.74M | 73.9M | 162.5M | -78.52M | 39.93M | 63.18M | 25.01M | 29.08M | 85.39M | -59.01M | 8.2M |
| FCF Margin % | 10.73% | -18.57% | 26.52% | 61.42% | -32.14% | 15.38% | 25.23% | 10.34% | 14.13% | 36.96% | -27.87% | 4.96% |
| FCF Growth % | 136.64% | -232.08% | 16.97% | 549.65% | -370.01% | -53.24% | 207.07% | 205% | 262.15% | 457.97% | -8016.23% | 162.48% |
| FCF per Share | 0.17 | -0.31 | 0.43 | 0.96 | -0.47 | 0.24 | 0.38 | 0.15 | 0.17 | 0.51 | -0.36 | 0.05 |
| FCF Conversion (FCF/Net Income) | 9.34x | -0.18x | 1.03x | 2.40x | 1.07x | 0.28x | 1.93x | 0.75x | 1.76x | 1.86x | 0.90x | 7.36x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |